FDDA Utilization Study (FDDAU)
Not Applicable
Terminated
- Conditions
- Fatigue
- Interventions
- Other: Fatigue Differential Diagnosis Aid
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT05861492
- Locations
- ๐จ๐ญ
QualiPro Schweiz AG, Kriens, Luzern, Switzerland
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05766839
- Locations
- ๐บ๐ธ
UF Health Pediatric Multispecialty Center, Jacksonville, Florida, United States
๐บ๐ธMiller School of Medicine, University of Miami, Miami, Florida, United States
๐ฎ๐ฑShaare Zedek Medical Center, Jerusalem, Israel
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 1195
- Registration Number
- NCT03888066
- Locations
- ๐บ๐ธ
Investigator Site 11-088, Haddon Heights, New Jersey, United States
๐บ๐ธInvestigator Site 11-148, New Brunswick, New Jersey, United States
๐บ๐ธInvestigator Site 11-054, Linden, New Jersey, United States
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT03087058
- Locations
- ๐บ๐ธ
Investigator Site 1101, Kansas City, Kansas, United States
๐ง๐ฌInvestigator Site 1401, Sofia, Bulgaria
๐ต๐ฑInvestigator Site 5404, Gdansk, Poland
ยฉ Copyright 2025. All Rights Reserved by MedPath